Investment Confidence and Return Evidence Are Moving in Opposite Directions
The scale of AI capital commitment is not in question — what is in question is whether that commitment is connected to any outcome executives can point to. A 2025 MIT study analyzing 150 executive interviews and 300 public AI deployments found approximately 95% of generative AI pilots failing to deliver measurable ROI, a figure that, if accurate, makes the investment cycle look less like patient capital and more like sunk cost accumulation. McKinsey's November 2025 survey reported more than 80% of enterprises seeing no meaningful EBIT impact from AI despite adoption; BCG found 60% generating no material value. Global startup funding reached a record $297 billion in Q1 2026, with 65% concentrated in four frontier AI companies — the long tail is not sharing in the momentum.
The executives who commissioned these deployments are not exiting the AI conversation. They are, however, starting to use language that was absent eighteen months ago: the word 'negligible' appears in Federal Reserve survey responses where 'transformative' appeared before. The AI productivity stalls documented across nearly 6,000 CEOs in the US, UK, Germany, and Australia represent a cross-sectional consensus that individual company results cannot explain away. The labs that built the infrastructure will argue the returns are coming — but the enterprises writing the deployment checks have already updated their vocabulary, and that update is irreversible.